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Introduction and aims: Meningococcal disease caused by Neisseria meningitidis  is global 
issue and it´s known for its epidemical potential. In Europe, this disease is most often caused 
by B and C serotype. Main aim was to track occurence and other epidemiologic aspects 
related to invasive meningococcal disease (IMD) in the Czech Republic from  2007 to 2016, 
focusing on serotype B and summarize available vaccinations which are used to fight disease 
mentioned above. Another was to analyse usage of Bexsero vaccination in the Czech 
Republic, hand in hand with number of spontaneous reports of adverse events after 
vaccination. 
Methodology: To assess epidemiologic aspects related to IMD data from the Centre of 
epidemiology and microbiology were used (years 2007 – 2016). Vaccination utilization was 
analysed based on data from the State Institue of Drug Control and expressed as number of 
packages. Central database of spontaneous adverse events reports was used to determine 
number and character of reports. 
Results: In period 2007-2016 there was a decrease in  meningococcal disease occurence 
caused by serotype B. This serotype was the most common in the Czech Republic and the 
most threatened group were children of age 0-4 years and 15-19 years. Death is also most 
often caused by serotype B, especially in age group 0-11 months. Vaccin Bexsero has been 
available on the Czech market since 2014 and its usage had increasing tendency. In 2017 the 
vaccine utilization  decreased by 16,2 % compare to 2016. Central database of spontaneous 
adverse  events has received 61 reports and 53 cases suspicion of an adverse effects (AEs). 
Erythema and pain in inject spot were most frequently reported local AEs. Fever and vomiting 
were most frequently reported system reactions. Twenty-four reported suspected AEs were 
unexpected. 
Conclusion: Decreasing trend in meningococcal disease in the Czech Republic caused by 
serotype B has been shown. Vaccine Bexsero has proved to be a  profitable choice in the fight 
against this disease, but it is still important to continue monitoring its adverse effects. 
 
